Brief: Neubase Reports Business Update And Financial Results For The First Quarter Of 2023
11/05/2023 22:09
May 11 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS INC Q1 LOSS PER SHARE $0.12
* NEUBASE REPORTS BUSINESS UPDATE AND FINANCIAL RESULTS FOR
THE
FIRST QUARTER OF 2023
* NEUBASE THERAPEUTICS INC - AS OF MARCH 31, 2023, CO HAD
CASH AND
CASH EQUIVALENTS OF ABOUT $13.8 MILLION
* NEUBASE THERAPEUTICS - SEES CURRENT CASH & CASH
EQUIVALENTS ARE
SUFFICIENT TO FUND CURRENTLY PLANNED OPERATING & CAPEX INTO Q2
OF 2024
Source text for Eikon: ID:nGNX22Qjdk
Further company coverage: NBSE.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet